argenx SE
OTC:ARGNF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
argenx SE
OTC:ARGNF
|
NL |
|
Yamaha Corp
F:YHAA
|
JP |
|
1
|
1000 Yatirimlar Holding AS
IST:BINHO.E
|
TR |
|
N
|
Next Eye Co Ltd
KOSDAQ:137940
|
KR |
|
Cranswick PLC
OTC:CRWKF
|
UK |
|
Greenidge Generation Holdings Inc
NASDAQ:VIP
|
US |
|
G
|
GE Vernova LLC
BMV:GEV
|
US |
|
G
|
Genel Energy PLC
F:4VL
|
UK |
|
E
|
EdiliziAcrobatica SpA
PAR:ALEAC
|
IT |
|
W
|
Western Exploration Inc
XTSX:WEX
|
US |
|
B
|
Binakarya Jaya Abadi Tbk PT
IDX:BIKA
|
ID |
|
O
|
Old Mutual Ltd
JSE:OMU
|
ZA |
|
Zhejiang Meilun Elevator Co Ltd
SSE:603321
|
CN |
|
Ethema Health Corp
OTC:GRST
|
US |
|
T
|
Tera Science Co Ltd
KOSDAQ:073640
|
KR |
|
E
|
E-Tron Co Ltd
KOSDAQ:096040
|
KR |
Bankruptcy Probability
argenx SE's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
argenx SE Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NL |
|
argenx SE
XBRU:ARGX
|
48.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
504B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
242B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
195.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
135.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
80.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
57.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Biogen Inc
NASDAQ:BIIB
|
37.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
argenx SE's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, argenx SE has total debt of 36m USD. This includes both short-term (0 USD) and long-term (36m USD) debt.
You can find a full breakdown on its Balance Sheet.